Metabolic Syndrome :: From Risk Factors to Management /
Annotation Increased caloric intake, increased refined carbohydrate consumption, and physical inactivity have led to an explosion in the worldwide incidence of abdominal obesity and the emerging epidemic of insulin resistance, resulting in an increase of metabolic syndrome. Physicians can use the me...
Gespeichert in:
1. Verfasser: | |
---|---|
Weitere Verfasser: | |
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Torino :
SEEd,
©2012.
|
Ausgabe: | 1st ed. |
Schlagworte: | |
Online-Zugang: | DE-862 DE-863 |
Zusammenfassung: | Annotation Increased caloric intake, increased refined carbohydrate consumption, and physical inactivity have led to an explosion in the worldwide incidence of abdominal obesity and the emerging epidemic of insulin resistance, resulting in an increase of metabolic syndrome. Physicians can use the metabolic syndrome concept to guide focused lifestyle changes, lower blood pressure goals, and earlier intervention with aspirin, LDL-lowering drugs, and perhaps insulin-sensitizing medications. The comprehensive ABCDE approach presented in this book provides a memory tool for use in everyday clinical practice. In this unique, easy-to-read text, the 17 most important clinical trials in the field of the metabolic syndrome are presented, that every clinician should know. |
Beschreibung: | 1 online resource : illustrations |
Bibliographie: | Includes bibliographical references. |
ISBN: | 9788897419204 8897419208 8897419194 9788897419198 |
Internformat
MARC
LEADER | 00000cam a2200000 a 4500 | ||
---|---|---|---|
001 | ZDB-4-EBA-ocn802055207 | ||
003 | OCoLC | ||
005 | 20241004212047.0 | ||
006 | m o d | ||
007 | cr cnu---unuuu | ||
008 | 120705s2012 it a ob 000 0 eng d | ||
040 | |a E7B |b eng |e pn |c E7B |d OCLCF |d DKDLA |d DEBBG |d N$T |d OCLCQ |d YDXCP |d OCLCQ |d EBLCP |d NKT |d DEBSZ |d D6H |d AZK |d LVT |d AGLDB |d MOR |d PIFAG |d ZCU |d MERUC |d OCLCQ |d U3W |d STF |d WRM |d VTS |d ICG |d NRAMU |d VT2 |d AU@ |d OCLCQ |d WYU |d DKC |d OCLCQ |d M8D |d OCLCQ |d AJS |d OCLCO |d OCLCQ |d OCLCO |d OCLCQ |d OCLCA |d SFB | ||
019 | |a 922903987 |a 961634754 |a 962653025 |a 988438114 |a 992002711 |a 1037705749 |a 1038664336 |a 1045529874 |a 1058138178 |a 1081215947 |a 1107344189 | ||
020 | |a 9788897419204 |q (electronic bk.) | ||
020 | |a 8897419208 |q (electronic bk.) | ||
020 | |a 8897419194 | ||
020 | |a 9788897419198 | ||
020 | |z 9788897419198 | ||
020 | |z 9788897419204 | ||
035 | |a (OCoLC)802055207 |z (OCoLC)922903987 |z (OCoLC)961634754 |z (OCoLC)962653025 |z (OCoLC)988438114 |z (OCoLC)992002711 |z (OCoLC)1037705749 |z (OCoLC)1038664336 |z (OCoLC)1045529874 |z (OCoLC)1058138178 |z (OCoLC)1081215947 |z (OCoLC)1107344189 | ||
050 | 4 | |a RC662.4 |b .B53 2012eb | |
072 | 7 | |a HEA |x 039000 |2 bisacsh | |
072 | 7 | |a MED |x 014000 |2 bisacsh | |
072 | 7 | |a MED |x 022000 |2 bisacsh | |
072 | 7 | |a MED |x 112000 |2 bisacsh | |
072 | 7 | |a MED |x 045000 |2 bisacsh | |
082 | 7 | |a 616.46207 |2 23 | |
049 | |a MAIN | ||
100 | 1 | |a Blaha, Michael J. | |
245 | 1 | 0 | |a Metabolic Syndrome : |b From Risk Factors to Management / |c Michael J. Blaha, Rajesh Tota-Maharaj. |
250 | |a 1st ed. | ||
260 | |a Torino : |b SEEd, |c ©2012. | ||
300 | |a 1 online resource : |b illustrations | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
347 | |a data file |2 rda | ||
504 | |a Includes bibliographical references. | ||
520 | 8 | |a Annotation Increased caloric intake, increased refined carbohydrate consumption, and physical inactivity have led to an explosion in the worldwide incidence of abdominal obesity and the emerging epidemic of insulin resistance, resulting in an increase of metabolic syndrome. Physicians can use the metabolic syndrome concept to guide focused lifestyle changes, lower blood pressure goals, and earlier intervention with aspirin, LDL-lowering drugs, and perhaps insulin-sensitizing medications. The comprehensive ABCDE approach presented in this book provides a memory tool for use in everyday clinical practice. In this unique, easy-to-read text, the 17 most important clinical trials in the field of the metabolic syndrome are presented, that every clinician should know. | |
588 | 0 | |a Print version record. | |
505 | 0 | |a Intro -- Title page -- Colophon -- Table of Contents -- Introduction -- The Metabolic Syndrome. A Global Problem -- Introduction -- A Global Problem -- What is the Metabolic Syndrome? -- Why is the Metabolic Syndrome Concept Useful? -- Misunderstandings about Use of Metabolic Syndrome -- Why is the Metabolic Syndrome so Interesting? -- References -- Defining the Metabolic Syndrome -- Early History of the Metabolic Syndrome -- Pathophysiology vs. Predictive Value -- Criticisms of the Metabolic Syndrome -- The "Harmonized" Definition of Metabolic Syndrome -- References -- Causes and Components of the Metabolic Syndrome -- Genetics of the Metabolic Syndrome -- Abdominal Obesity -- Insulin Resistance -- Atherogenic Dyslipidemia -- Essential Hypertension -- Glucose Intolerance -- Subclinical Inflammation -- Fatty Liver Disease -- Obstructive Sleep Apnea -- References -- Consequences of the Metabolic Syndrome -- Cardiovascular Disease -- Type 2 Diabetes -- Microalbuminuria and Chronic Kidney Disease -- Sexual Dysfunction (Men and Women) -- Cognitive Decline -- Cancer -- References -- The Comprehensive "ABCDE" Approach to Management -- Rationale for a Comprehensive Approach -- The ABCDE approach -- References -- Assessment of Cardiovascular Risk -- Traditional Risk Models -- Lifetime Risk -- Metabolic Syndrome and Unaccounted Risk -- Emerging Cardiometabolic Risk Factors -- Reclassification with the Metabolic Syndrome -- Novel Risk Detection Strategies -- References -- Aspirin and Antithrombotics -- Mechanisms of Increased Thrombosis in the Metabolic Syndrome -- Brief Overview of Platelet Function -- Therapies With Available Evidence -- Possible Aspirin Resistance in the Metabolic Syndrome -- Other Therapies -- Treatment recommendations -- References -- Blood Pressure -- Hypertension -- Definition. | |
505 | 8 | |a Mechanisms of Increased Blood Pressure in the Metabolic Syndrome -- Lifestyle Therapy -- Pharmacologic Agents: The Renin-Angiotensin-Aldosterone Axis -- Thiazide Diuretics -- Beta-Blockers -- Calcium Channel Blockers -- Metabolic Considerations. Progression to Diabetes -- Blood Pressure Target -- Guidelines and Recommendations -- References -- Cholesterol -- Atherogenic Dyslipidemia -- Mechanisms of Atherogenic Dyslipidemia -- Measurement -- Therapies with Available Evidence -- Guidelines and Recommendations -- References -- Diet and Weight Management -- Weight Loss -- The Mediterranean Diet -- The Low Glycemic Index Approach -- Sugar Sweetened Beverages -- The Benefit of Nuts -- Pharmacologic and Surgical Therapy for Obesity -- Refer to a Nutritionist? -- References -- Diabetes Prevention -- Progression to Type 2 Diabetes -- Clinical Trial Evidence -- Gaps in the Evidence -- Guidelines -- References -- Exercise Therapy -- Fitness -- Mechanisms of Harm from Sedentary Lifestyle: Decreased Fitness -- Mechanisms of Harm from Sedentary Lifestyle: Increased Fatness -- Exercise: A Selective Therapy for Metabolic Syndrome? -- Guideline Recommendations -- References -- Metabolic Syndrome in the Pediatric Population -- The Unique Challenge of Pediatric Metabolic Syndrome -- Defining Pediatric Metabolic Syndrome -- Scientific Statement from the American Heart Association -- Population-Based Treatment Strategies Targeted at Youth -- References -- Summary of Treatment Approaches -- Appendix. Clinical trials -- Finnish Diabetes Prevention Study -- Diabetes Prevention Program (DPP) -- JPAD Trial -- POPADAD Trial -- ACCORD Blood Pressure Trial -- JUPITER trial -- VA-HIT trial -- ACCORD Lipid trial -- AIM-HIGH trial -- JELIS trial -- Lyon Heart Study -- Esposito Mediterranean Diet Trial -- DREAM Trial -- ACT-NOW Trial -- CANOE trial -- Tjønna Exercise Trial. | |
505 | 8 | |a CPAP for the Metabolic Syndrome -- References -- Authors. | |
650 | 0 | |a Metabolic syndrome. |0 http://id.loc.gov/authorities/subjects/sh2005005763 | |
650 | 0 | |a Diabetes. |0 http://id.loc.gov/authorities/subjects/sh85037456 | |
650 | 2 | |a Metabolic Syndrome. | |
650 | 6 | |a Syndrome métabolique. | |
650 | 7 | |a HEALTH & FITNESS |x Diseases |x General. |2 bisacsh | |
650 | 7 | |a MEDICAL |x Clinical Medicine. |2 bisacsh | |
650 | 7 | |a MEDICAL |x Diseases. |2 bisacsh | |
650 | 7 | |a MEDICAL |x Evidence-Based Medicine. |2 bisacsh | |
650 | 7 | |a MEDICAL |x Internal Medicine. |2 bisacsh | |
650 | 7 | |a Diabetes |2 fast | |
650 | 7 | |a Metabolic syndrome |2 fast | |
700 | 1 | |a Tota-Maharaj, Rajesh. | |
776 | 0 | 8 | |i Print version: |a Blaha, Michael J. |t Metabolic syndrome. |b 1st ed. |d Torino : SEEd, ©2012 |z 9788897419198 |
966 | 4 | 0 | |l DE-862 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=783066 |3 Volltext |
966 | 4 | 0 | |l DE-863 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=783066 |3 Volltext |
938 | |a EBL - Ebook Library |b EBLB |n EBL934253 | ||
938 | |a ebrary |b EBRY |n ebr10572356 | ||
938 | |a EBSCOhost |b EBSC |n 783066 | ||
938 | |a YBP Library Services |b YANK |n 8923587 | ||
994 | |a 92 |b GEBAY | ||
912 | |a ZDB-4-EBA | ||
049 | |a DE-862 | ||
049 | |a DE-863 |
Datensatz im Suchindex
DE-BY-FWS_katkey | ZDB-4-EBA-ocn802055207 |
---|---|
_version_ | 1826941984709804032 |
adam_text | |
any_adam_object | |
author | Blaha, Michael J. |
author2 | Tota-Maharaj, Rajesh |
author2_role | |
author2_variant | r t m rtm |
author_facet | Blaha, Michael J. Tota-Maharaj, Rajesh |
author_role | |
author_sort | Blaha, Michael J. |
author_variant | m j b mj mjb |
building | Verbundindex |
bvnumber | localFWS |
callnumber-first | R - Medicine |
callnumber-label | RC662 |
callnumber-raw | RC662.4 .B53 2012eb |
callnumber-search | RC662.4 .B53 2012eb |
callnumber-sort | RC 3662.4 B53 42012EB |
callnumber-subject | RC - Internal Medicine |
collection | ZDB-4-EBA |
contents | Intro -- Title page -- Colophon -- Table of Contents -- Introduction -- The Metabolic Syndrome. A Global Problem -- Introduction -- A Global Problem -- What is the Metabolic Syndrome? -- Why is the Metabolic Syndrome Concept Useful? -- Misunderstandings about Use of Metabolic Syndrome -- Why is the Metabolic Syndrome so Interesting? -- References -- Defining the Metabolic Syndrome -- Early History of the Metabolic Syndrome -- Pathophysiology vs. Predictive Value -- Criticisms of the Metabolic Syndrome -- The "Harmonized" Definition of Metabolic Syndrome -- References -- Causes and Components of the Metabolic Syndrome -- Genetics of the Metabolic Syndrome -- Abdominal Obesity -- Insulin Resistance -- Atherogenic Dyslipidemia -- Essential Hypertension -- Glucose Intolerance -- Subclinical Inflammation -- Fatty Liver Disease -- Obstructive Sleep Apnea -- References -- Consequences of the Metabolic Syndrome -- Cardiovascular Disease -- Type 2 Diabetes -- Microalbuminuria and Chronic Kidney Disease -- Sexual Dysfunction (Men and Women) -- Cognitive Decline -- Cancer -- References -- The Comprehensive "ABCDE" Approach to Management -- Rationale for a Comprehensive Approach -- The ABCDE approach -- References -- Assessment of Cardiovascular Risk -- Traditional Risk Models -- Lifetime Risk -- Metabolic Syndrome and Unaccounted Risk -- Emerging Cardiometabolic Risk Factors -- Reclassification with the Metabolic Syndrome -- Novel Risk Detection Strategies -- References -- Aspirin and Antithrombotics -- Mechanisms of Increased Thrombosis in the Metabolic Syndrome -- Brief Overview of Platelet Function -- Therapies With Available Evidence -- Possible Aspirin Resistance in the Metabolic Syndrome -- Other Therapies -- Treatment recommendations -- References -- Blood Pressure -- Hypertension -- Definition. Mechanisms of Increased Blood Pressure in the Metabolic Syndrome -- Lifestyle Therapy -- Pharmacologic Agents: The Renin-Angiotensin-Aldosterone Axis -- Thiazide Diuretics -- Beta-Blockers -- Calcium Channel Blockers -- Metabolic Considerations. Progression to Diabetes -- Blood Pressure Target -- Guidelines and Recommendations -- References -- Cholesterol -- Atherogenic Dyslipidemia -- Mechanisms of Atherogenic Dyslipidemia -- Measurement -- Therapies with Available Evidence -- Guidelines and Recommendations -- References -- Diet and Weight Management -- Weight Loss -- The Mediterranean Diet -- The Low Glycemic Index Approach -- Sugar Sweetened Beverages -- The Benefit of Nuts -- Pharmacologic and Surgical Therapy for Obesity -- Refer to a Nutritionist? -- References -- Diabetes Prevention -- Progression to Type 2 Diabetes -- Clinical Trial Evidence -- Gaps in the Evidence -- Guidelines -- References -- Exercise Therapy -- Fitness -- Mechanisms of Harm from Sedentary Lifestyle: Decreased Fitness -- Mechanisms of Harm from Sedentary Lifestyle: Increased Fatness -- Exercise: A Selective Therapy for Metabolic Syndrome? -- Guideline Recommendations -- References -- Metabolic Syndrome in the Pediatric Population -- The Unique Challenge of Pediatric Metabolic Syndrome -- Defining Pediatric Metabolic Syndrome -- Scientific Statement from the American Heart Association -- Population-Based Treatment Strategies Targeted at Youth -- References -- Summary of Treatment Approaches -- Appendix. Clinical trials -- Finnish Diabetes Prevention Study -- Diabetes Prevention Program (DPP) -- JPAD Trial -- POPADAD Trial -- ACCORD Blood Pressure Trial -- JUPITER trial -- VA-HIT trial -- ACCORD Lipid trial -- AIM-HIGH trial -- JELIS trial -- Lyon Heart Study -- Esposito Mediterranean Diet Trial -- DREAM Trial -- ACT-NOW Trial -- CANOE trial -- Tjønna Exercise Trial. CPAP for the Metabolic Syndrome -- References -- Authors. |
ctrlnum | (OCoLC)802055207 |
dewey-full | 616.46207 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.46207 |
dewey-search | 616.46207 |
dewey-sort | 3616.46207 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
edition | 1st ed. |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>07500cam a2200709 a 4500</leader><controlfield tag="001">ZDB-4-EBA-ocn802055207</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu---unuuu</controlfield><controlfield tag="008">120705s2012 it a ob 000 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">E7B</subfield><subfield code="b">eng</subfield><subfield code="e">pn</subfield><subfield code="c">E7B</subfield><subfield code="d">OCLCF</subfield><subfield code="d">DKDLA</subfield><subfield code="d">DEBBG</subfield><subfield code="d">N$T</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">YDXCP</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">EBLCP</subfield><subfield code="d">NKT</subfield><subfield code="d">DEBSZ</subfield><subfield code="d">D6H</subfield><subfield code="d">AZK</subfield><subfield code="d">LVT</subfield><subfield code="d">AGLDB</subfield><subfield code="d">MOR</subfield><subfield code="d">PIFAG</subfield><subfield code="d">ZCU</subfield><subfield code="d">MERUC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">U3W</subfield><subfield code="d">STF</subfield><subfield code="d">WRM</subfield><subfield code="d">VTS</subfield><subfield code="d">ICG</subfield><subfield code="d">NRAMU</subfield><subfield code="d">VT2</subfield><subfield code="d">AU@</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">WYU</subfield><subfield code="d">DKC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">M8D</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">AJS</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCA</subfield><subfield code="d">SFB</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">922903987</subfield><subfield code="a">961634754</subfield><subfield code="a">962653025</subfield><subfield code="a">988438114</subfield><subfield code="a">992002711</subfield><subfield code="a">1037705749</subfield><subfield code="a">1038664336</subfield><subfield code="a">1045529874</subfield><subfield code="a">1058138178</subfield><subfield code="a">1081215947</subfield><subfield code="a">1107344189</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9788897419204</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">8897419208</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">8897419194</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9788897419198</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9788897419198</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9788897419204</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)802055207</subfield><subfield code="z">(OCoLC)922903987</subfield><subfield code="z">(OCoLC)961634754</subfield><subfield code="z">(OCoLC)962653025</subfield><subfield code="z">(OCoLC)988438114</subfield><subfield code="z">(OCoLC)992002711</subfield><subfield code="z">(OCoLC)1037705749</subfield><subfield code="z">(OCoLC)1038664336</subfield><subfield code="z">(OCoLC)1045529874</subfield><subfield code="z">(OCoLC)1058138178</subfield><subfield code="z">(OCoLC)1081215947</subfield><subfield code="z">(OCoLC)1107344189</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC662.4</subfield><subfield code="b">.B53 2012eb</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">HEA</subfield><subfield code="x">039000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">014000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">022000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">112000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">045000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">616.46207</subfield><subfield code="2">23</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Blaha, Michael J.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Metabolic Syndrome :</subfield><subfield code="b">From Risk Factors to Management /</subfield><subfield code="c">Michael J. Blaha, Rajesh Tota-Maharaj.</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Torino :</subfield><subfield code="b">SEEd,</subfield><subfield code="c">©2012.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="a">data file</subfield><subfield code="2">rda</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="520" ind1="8" ind2=" "><subfield code="a">Annotation Increased caloric intake, increased refined carbohydrate consumption, and physical inactivity have led to an explosion in the worldwide incidence of abdominal obesity and the emerging epidemic of insulin resistance, resulting in an increase of metabolic syndrome. Physicians can use the metabolic syndrome concept to guide focused lifestyle changes, lower blood pressure goals, and earlier intervention with aspirin, LDL-lowering drugs, and perhaps insulin-sensitizing medications. The comprehensive ABCDE approach presented in this book provides a memory tool for use in everyday clinical practice. In this unique, easy-to-read text, the 17 most important clinical trials in the field of the metabolic syndrome are presented, that every clinician should know.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Intro -- Title page -- Colophon -- Table of Contents -- Introduction -- The Metabolic Syndrome. A Global Problem -- Introduction -- A Global Problem -- What is the Metabolic Syndrome? -- Why is the Metabolic Syndrome Concept Useful? -- Misunderstandings about Use of Metabolic Syndrome -- Why is the Metabolic Syndrome so Interesting? -- References -- Defining the Metabolic Syndrome -- Early History of the Metabolic Syndrome -- Pathophysiology vs. Predictive Value -- Criticisms of the Metabolic Syndrome -- The "Harmonized" Definition of Metabolic Syndrome -- References -- Causes and Components of the Metabolic Syndrome -- Genetics of the Metabolic Syndrome -- Abdominal Obesity -- Insulin Resistance -- Atherogenic Dyslipidemia -- Essential Hypertension -- Glucose Intolerance -- Subclinical Inflammation -- Fatty Liver Disease -- Obstructive Sleep Apnea -- References -- Consequences of the Metabolic Syndrome -- Cardiovascular Disease -- Type 2 Diabetes -- Microalbuminuria and Chronic Kidney Disease -- Sexual Dysfunction (Men and Women) -- Cognitive Decline -- Cancer -- References -- The Comprehensive "ABCDE" Approach to Management -- Rationale for a Comprehensive Approach -- The ABCDE approach -- References -- Assessment of Cardiovascular Risk -- Traditional Risk Models -- Lifetime Risk -- Metabolic Syndrome and Unaccounted Risk -- Emerging Cardiometabolic Risk Factors -- Reclassification with the Metabolic Syndrome -- Novel Risk Detection Strategies -- References -- Aspirin and Antithrombotics -- Mechanisms of Increased Thrombosis in the Metabolic Syndrome -- Brief Overview of Platelet Function -- Therapies With Available Evidence -- Possible Aspirin Resistance in the Metabolic Syndrome -- Other Therapies -- Treatment recommendations -- References -- Blood Pressure -- Hypertension -- Definition.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Mechanisms of Increased Blood Pressure in the Metabolic Syndrome -- Lifestyle Therapy -- Pharmacologic Agents: The Renin-Angiotensin-Aldosterone Axis -- Thiazide Diuretics -- Beta-Blockers -- Calcium Channel Blockers -- Metabolic Considerations. Progression to Diabetes -- Blood Pressure Target -- Guidelines and Recommendations -- References -- Cholesterol -- Atherogenic Dyslipidemia -- Mechanisms of Atherogenic Dyslipidemia -- Measurement -- Therapies with Available Evidence -- Guidelines and Recommendations -- References -- Diet and Weight Management -- Weight Loss -- The Mediterranean Diet -- The Low Glycemic Index Approach -- Sugar Sweetened Beverages -- The Benefit of Nuts -- Pharmacologic and Surgical Therapy for Obesity -- Refer to a Nutritionist? -- References -- Diabetes Prevention -- Progression to Type 2 Diabetes -- Clinical Trial Evidence -- Gaps in the Evidence -- Guidelines -- References -- Exercise Therapy -- Fitness -- Mechanisms of Harm from Sedentary Lifestyle: Decreased Fitness -- Mechanisms of Harm from Sedentary Lifestyle: Increased Fatness -- Exercise: A Selective Therapy for Metabolic Syndrome? -- Guideline Recommendations -- References -- Metabolic Syndrome in the Pediatric Population -- The Unique Challenge of Pediatric Metabolic Syndrome -- Defining Pediatric Metabolic Syndrome -- Scientific Statement from the American Heart Association -- Population-Based Treatment Strategies Targeted at Youth -- References -- Summary of Treatment Approaches -- Appendix. Clinical trials -- Finnish Diabetes Prevention Study -- Diabetes Prevention Program (DPP) -- JPAD Trial -- POPADAD Trial -- ACCORD Blood Pressure Trial -- JUPITER trial -- VA-HIT trial -- ACCORD Lipid trial -- AIM-HIGH trial -- JELIS trial -- Lyon Heart Study -- Esposito Mediterranean Diet Trial -- DREAM Trial -- ACT-NOW Trial -- CANOE trial -- Tjønna Exercise Trial.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">CPAP for the Metabolic Syndrome -- References -- Authors.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Metabolic syndrome.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh2005005763</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Diabetes.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85037456</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Metabolic Syndrome.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Syndrome métabolique.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS</subfield><subfield code="x">Diseases</subfield><subfield code="x">General.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Clinical Medicine.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Diseases.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Evidence-Based Medicine.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Internal Medicine.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Diabetes</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Metabolic syndrome</subfield><subfield code="2">fast</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tota-Maharaj, Rajesh.</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Blaha, Michael J.</subfield><subfield code="t">Metabolic syndrome.</subfield><subfield code="b">1st ed.</subfield><subfield code="d">Torino : SEEd, ©2012</subfield><subfield code="z">9788897419198</subfield></datafield><datafield tag="966" ind1="4" ind2="0"><subfield code="l">DE-862</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=783066</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="4" ind2="0"><subfield code="l">DE-863</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=783066</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBL - Ebook Library</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL934253</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ebrary</subfield><subfield code="b">EBRY</subfield><subfield code="n">ebr10572356</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">783066</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">8923587</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-862</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
id | ZDB-4-EBA-ocn802055207 |
illustrated | Illustrated |
indexdate | 2025-03-18T14:20:48Z |
institution | BVB |
isbn | 9788897419204 8897419208 8897419194 9788897419198 |
language | English |
oclc_num | 802055207 |
open_access_boolean | |
owner | MAIN DE-862 DE-BY-FWS DE-863 DE-BY-FWS |
owner_facet | MAIN DE-862 DE-BY-FWS DE-863 DE-BY-FWS |
physical | 1 online resource : illustrations |
psigel | ZDB-4-EBA FWS_PDA_EBA ZDB-4-EBA |
publishDate | 2012 |
publishDateSearch | 2012 |
publishDateSort | 2012 |
publisher | SEEd, |
record_format | marc |
spelling | Blaha, Michael J. Metabolic Syndrome : From Risk Factors to Management / Michael J. Blaha, Rajesh Tota-Maharaj. 1st ed. Torino : SEEd, ©2012. 1 online resource : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier data file rda Includes bibliographical references. Annotation Increased caloric intake, increased refined carbohydrate consumption, and physical inactivity have led to an explosion in the worldwide incidence of abdominal obesity and the emerging epidemic of insulin resistance, resulting in an increase of metabolic syndrome. Physicians can use the metabolic syndrome concept to guide focused lifestyle changes, lower blood pressure goals, and earlier intervention with aspirin, LDL-lowering drugs, and perhaps insulin-sensitizing medications. The comprehensive ABCDE approach presented in this book provides a memory tool for use in everyday clinical practice. In this unique, easy-to-read text, the 17 most important clinical trials in the field of the metabolic syndrome are presented, that every clinician should know. Print version record. Intro -- Title page -- Colophon -- Table of Contents -- Introduction -- The Metabolic Syndrome. A Global Problem -- Introduction -- A Global Problem -- What is the Metabolic Syndrome? -- Why is the Metabolic Syndrome Concept Useful? -- Misunderstandings about Use of Metabolic Syndrome -- Why is the Metabolic Syndrome so Interesting? -- References -- Defining the Metabolic Syndrome -- Early History of the Metabolic Syndrome -- Pathophysiology vs. Predictive Value -- Criticisms of the Metabolic Syndrome -- The "Harmonized" Definition of Metabolic Syndrome -- References -- Causes and Components of the Metabolic Syndrome -- Genetics of the Metabolic Syndrome -- Abdominal Obesity -- Insulin Resistance -- Atherogenic Dyslipidemia -- Essential Hypertension -- Glucose Intolerance -- Subclinical Inflammation -- Fatty Liver Disease -- Obstructive Sleep Apnea -- References -- Consequences of the Metabolic Syndrome -- Cardiovascular Disease -- Type 2 Diabetes -- Microalbuminuria and Chronic Kidney Disease -- Sexual Dysfunction (Men and Women) -- Cognitive Decline -- Cancer -- References -- The Comprehensive "ABCDE" Approach to Management -- Rationale for a Comprehensive Approach -- The ABCDE approach -- References -- Assessment of Cardiovascular Risk -- Traditional Risk Models -- Lifetime Risk -- Metabolic Syndrome and Unaccounted Risk -- Emerging Cardiometabolic Risk Factors -- Reclassification with the Metabolic Syndrome -- Novel Risk Detection Strategies -- References -- Aspirin and Antithrombotics -- Mechanisms of Increased Thrombosis in the Metabolic Syndrome -- Brief Overview of Platelet Function -- Therapies With Available Evidence -- Possible Aspirin Resistance in the Metabolic Syndrome -- Other Therapies -- Treatment recommendations -- References -- Blood Pressure -- Hypertension -- Definition. Mechanisms of Increased Blood Pressure in the Metabolic Syndrome -- Lifestyle Therapy -- Pharmacologic Agents: The Renin-Angiotensin-Aldosterone Axis -- Thiazide Diuretics -- Beta-Blockers -- Calcium Channel Blockers -- Metabolic Considerations. Progression to Diabetes -- Blood Pressure Target -- Guidelines and Recommendations -- References -- Cholesterol -- Atherogenic Dyslipidemia -- Mechanisms of Atherogenic Dyslipidemia -- Measurement -- Therapies with Available Evidence -- Guidelines and Recommendations -- References -- Diet and Weight Management -- Weight Loss -- The Mediterranean Diet -- The Low Glycemic Index Approach -- Sugar Sweetened Beverages -- The Benefit of Nuts -- Pharmacologic and Surgical Therapy for Obesity -- Refer to a Nutritionist? -- References -- Diabetes Prevention -- Progression to Type 2 Diabetes -- Clinical Trial Evidence -- Gaps in the Evidence -- Guidelines -- References -- Exercise Therapy -- Fitness -- Mechanisms of Harm from Sedentary Lifestyle: Decreased Fitness -- Mechanisms of Harm from Sedentary Lifestyle: Increased Fatness -- Exercise: A Selective Therapy for Metabolic Syndrome? -- Guideline Recommendations -- References -- Metabolic Syndrome in the Pediatric Population -- The Unique Challenge of Pediatric Metabolic Syndrome -- Defining Pediatric Metabolic Syndrome -- Scientific Statement from the American Heart Association -- Population-Based Treatment Strategies Targeted at Youth -- References -- Summary of Treatment Approaches -- Appendix. Clinical trials -- Finnish Diabetes Prevention Study -- Diabetes Prevention Program (DPP) -- JPAD Trial -- POPADAD Trial -- ACCORD Blood Pressure Trial -- JUPITER trial -- VA-HIT trial -- ACCORD Lipid trial -- AIM-HIGH trial -- JELIS trial -- Lyon Heart Study -- Esposito Mediterranean Diet Trial -- DREAM Trial -- ACT-NOW Trial -- CANOE trial -- Tjønna Exercise Trial. CPAP for the Metabolic Syndrome -- References -- Authors. Metabolic syndrome. http://id.loc.gov/authorities/subjects/sh2005005763 Diabetes. http://id.loc.gov/authorities/subjects/sh85037456 Metabolic Syndrome. Syndrome métabolique. HEALTH & FITNESS Diseases General. bisacsh MEDICAL Clinical Medicine. bisacsh MEDICAL Diseases. bisacsh MEDICAL Evidence-Based Medicine. bisacsh MEDICAL Internal Medicine. bisacsh Diabetes fast Metabolic syndrome fast Tota-Maharaj, Rajesh. Print version: Blaha, Michael J. Metabolic syndrome. 1st ed. Torino : SEEd, ©2012 9788897419198 |
spellingShingle | Blaha, Michael J. Metabolic Syndrome : From Risk Factors to Management / Intro -- Title page -- Colophon -- Table of Contents -- Introduction -- The Metabolic Syndrome. A Global Problem -- Introduction -- A Global Problem -- What is the Metabolic Syndrome? -- Why is the Metabolic Syndrome Concept Useful? -- Misunderstandings about Use of Metabolic Syndrome -- Why is the Metabolic Syndrome so Interesting? -- References -- Defining the Metabolic Syndrome -- Early History of the Metabolic Syndrome -- Pathophysiology vs. Predictive Value -- Criticisms of the Metabolic Syndrome -- The "Harmonized" Definition of Metabolic Syndrome -- References -- Causes and Components of the Metabolic Syndrome -- Genetics of the Metabolic Syndrome -- Abdominal Obesity -- Insulin Resistance -- Atherogenic Dyslipidemia -- Essential Hypertension -- Glucose Intolerance -- Subclinical Inflammation -- Fatty Liver Disease -- Obstructive Sleep Apnea -- References -- Consequences of the Metabolic Syndrome -- Cardiovascular Disease -- Type 2 Diabetes -- Microalbuminuria and Chronic Kidney Disease -- Sexual Dysfunction (Men and Women) -- Cognitive Decline -- Cancer -- References -- The Comprehensive "ABCDE" Approach to Management -- Rationale for a Comprehensive Approach -- The ABCDE approach -- References -- Assessment of Cardiovascular Risk -- Traditional Risk Models -- Lifetime Risk -- Metabolic Syndrome and Unaccounted Risk -- Emerging Cardiometabolic Risk Factors -- Reclassification with the Metabolic Syndrome -- Novel Risk Detection Strategies -- References -- Aspirin and Antithrombotics -- Mechanisms of Increased Thrombosis in the Metabolic Syndrome -- Brief Overview of Platelet Function -- Therapies With Available Evidence -- Possible Aspirin Resistance in the Metabolic Syndrome -- Other Therapies -- Treatment recommendations -- References -- Blood Pressure -- Hypertension -- Definition. Mechanisms of Increased Blood Pressure in the Metabolic Syndrome -- Lifestyle Therapy -- Pharmacologic Agents: The Renin-Angiotensin-Aldosterone Axis -- Thiazide Diuretics -- Beta-Blockers -- Calcium Channel Blockers -- Metabolic Considerations. Progression to Diabetes -- Blood Pressure Target -- Guidelines and Recommendations -- References -- Cholesterol -- Atherogenic Dyslipidemia -- Mechanisms of Atherogenic Dyslipidemia -- Measurement -- Therapies with Available Evidence -- Guidelines and Recommendations -- References -- Diet and Weight Management -- Weight Loss -- The Mediterranean Diet -- The Low Glycemic Index Approach -- Sugar Sweetened Beverages -- The Benefit of Nuts -- Pharmacologic and Surgical Therapy for Obesity -- Refer to a Nutritionist? -- References -- Diabetes Prevention -- Progression to Type 2 Diabetes -- Clinical Trial Evidence -- Gaps in the Evidence -- Guidelines -- References -- Exercise Therapy -- Fitness -- Mechanisms of Harm from Sedentary Lifestyle: Decreased Fitness -- Mechanisms of Harm from Sedentary Lifestyle: Increased Fatness -- Exercise: A Selective Therapy for Metabolic Syndrome? -- Guideline Recommendations -- References -- Metabolic Syndrome in the Pediatric Population -- The Unique Challenge of Pediatric Metabolic Syndrome -- Defining Pediatric Metabolic Syndrome -- Scientific Statement from the American Heart Association -- Population-Based Treatment Strategies Targeted at Youth -- References -- Summary of Treatment Approaches -- Appendix. Clinical trials -- Finnish Diabetes Prevention Study -- Diabetes Prevention Program (DPP) -- JPAD Trial -- POPADAD Trial -- ACCORD Blood Pressure Trial -- JUPITER trial -- VA-HIT trial -- ACCORD Lipid trial -- AIM-HIGH trial -- JELIS trial -- Lyon Heart Study -- Esposito Mediterranean Diet Trial -- DREAM Trial -- ACT-NOW Trial -- CANOE trial -- Tjønna Exercise Trial. CPAP for the Metabolic Syndrome -- References -- Authors. Metabolic syndrome. http://id.loc.gov/authorities/subjects/sh2005005763 Diabetes. http://id.loc.gov/authorities/subjects/sh85037456 Metabolic Syndrome. Syndrome métabolique. HEALTH & FITNESS Diseases General. bisacsh MEDICAL Clinical Medicine. bisacsh MEDICAL Diseases. bisacsh MEDICAL Evidence-Based Medicine. bisacsh MEDICAL Internal Medicine. bisacsh Diabetes fast Metabolic syndrome fast |
subject_GND | http://id.loc.gov/authorities/subjects/sh2005005763 http://id.loc.gov/authorities/subjects/sh85037456 |
title | Metabolic Syndrome : From Risk Factors to Management / |
title_auth | Metabolic Syndrome : From Risk Factors to Management / |
title_exact_search | Metabolic Syndrome : From Risk Factors to Management / |
title_full | Metabolic Syndrome : From Risk Factors to Management / Michael J. Blaha, Rajesh Tota-Maharaj. |
title_fullStr | Metabolic Syndrome : From Risk Factors to Management / Michael J. Blaha, Rajesh Tota-Maharaj. |
title_full_unstemmed | Metabolic Syndrome : From Risk Factors to Management / Michael J. Blaha, Rajesh Tota-Maharaj. |
title_short | Metabolic Syndrome : |
title_sort | metabolic syndrome from risk factors to management |
title_sub | From Risk Factors to Management / |
topic | Metabolic syndrome. http://id.loc.gov/authorities/subjects/sh2005005763 Diabetes. http://id.loc.gov/authorities/subjects/sh85037456 Metabolic Syndrome. Syndrome métabolique. HEALTH & FITNESS Diseases General. bisacsh MEDICAL Clinical Medicine. bisacsh MEDICAL Diseases. bisacsh MEDICAL Evidence-Based Medicine. bisacsh MEDICAL Internal Medicine. bisacsh Diabetes fast Metabolic syndrome fast |
topic_facet | Metabolic syndrome. Diabetes. Metabolic Syndrome. Syndrome métabolique. HEALTH & FITNESS Diseases General. MEDICAL Clinical Medicine. MEDICAL Diseases. MEDICAL Evidence-Based Medicine. MEDICAL Internal Medicine. Diabetes Metabolic syndrome |
work_keys_str_mv | AT blahamichaelj metabolicsyndromefromriskfactorstomanagement AT totamaharajrajesh metabolicsyndromefromriskfactorstomanagement |